Related Experiment Video
Updated: Jul 16, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Why blacks do not take part in HIV vaccine trials
Demetrius L Moutsiakis1, P Nancy Chin
1Department of Community and Preventive Medicine, University at Buffalo, Buffalo, NY, USA.
Background:
AIDS is still a major cause of death. To combat this disease, researchers are developing a vaccine. Although blacks account for most new infections in the United States, they account for a low percent of experimental vaccine recipients. This study, conducted in a mid-sized U.S. city where vaccine trials are held, seeks to learn why.
Methods:
We conducted 11 in-depth ethnographic interviews. Two groups were targeted: blacks who had not participated in HIV vaccine trials and blacks who had.
Results:
Overall, three major causes of nonparticipation were identified: misinformation, fear/mistrust and stigma. Factors that favored participation included having close friends with HIV and being homosexual.
Conclusions:
HIV is considered by many blacks to be a gay, white disease. Steps to increase participation must include efforts to destigmatize the condition and disseminate accurate information. Efforts to address historical causes of mistrust through "education" alone are insufficient. Trust needs to be earned through long-term relationships with black communities.
More Related Videos
Related Concept Videos
Ethics in Research
Blinding
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bias in Epidemiological Studies

